ORGANOCLICK AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.88 SEK | +1.57% |
|
+2.65% | +22.01% |
| Jun. 14 | OrganoClick AB Announces CFO Changes | CI |
| May. 15 | OrganoClick AB Approves Board Changes | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 497.4 | 1,013 | 685.6 | 293.8 | 311.5 | 374.8 | - | - |
| Enterprise Value (EV) 1 | 497.4 | 1,019 | 698.5 | 327.2 | 349.2 | 414.8 | 399.8 | 391.8 |
| P/E ratio | -20.8 x | -42.3 x | -20.6 x | -6.67 x | -19.9 x | -54.6 x | 38.2 x | 21.2 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 10.5 x | 6.23 x | 2.55 x | 2.14 x | 2.42 x | 2.64 x | 2.23 x |
| EV / Revenue | - | 10.6 x | 6.35 x | 2.84 x | 2.39 x | 2.68 x | 2.82 x | 2.33 x |
| EV / EBITDA | - | -229 x | -53.8 x | -174 x | 59.7 x | 24.4 x | 12.5 x | 10.6 x |
| EV / FCF | - | -73.2 x | -13.3 x | -14.6 x | -43.2 x | -51.9 x | 22.2 x | 28 x |
| FCF Yield | - | -1.37% | -7.49% | -6.87% | -2.31% | -1.93% | 4.5% | 3.57% |
| Price to Book | - | 18.7 x | 6.86 x | 5 x | 6.99 x | 10.1 x | 7.96 x | 5.79 x |
| Nbr of stocks (in thousands) | 92,113 | 92,113 | 97,950 | 97,950 | 97,950 | 98,118 | - | - |
| Reference price 2 | 5.400 | 11.00 | 7.000 | 3.000 | 3.180 | 3.820 | 3.820 | 3.820 |
| Announcement Date | 4/15/20 | 2/17/21 | 2/18/22 | 2/15/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 96.46 | 110.1 | 115 | 145.9 | 155 | 142 | 168 |
| EBITDA 1 | - | -4.46 | -12.99 | -1.882 | 5.85 | 17 | 32 | 37 |
| EBIT 1 | - | -17.1 | -28.59 | -28.5 | -9.23 | - | 15 | 24 |
| Operating Margin | - | -17.73% | -25.98% | -24.77% | -6.33% | - | 10.56% | 14.29% |
| Earnings before Tax (EBT) 1 | - | -19.53 | -31.17 | -41.72 | -14.09 | -6 | 10 | 18 |
| Net income 1 | -20.39 | -23.65 | -32.69 | -44.4 | -15.77 | -6 | 10 | 18 |
| Net margin | - | -24.51% | -29.7% | -38.59% | -10.81% | -3.87% | 7.04% | 10.71% |
| EPS 2 | -0.2600 | -0.2600 | -0.3400 | -0.4500 | -0.1600 | -0.0700 | 0.1000 | 0.1800 |
| Free Cash Flow 1 | - | -13.93 | -52.34 | -22.47 | -8.077 | -8 | 18 | 14 |
| FCF margin | - | -14.44% | -47.55% | -19.53% | -5.54% | -5.16% | 12.68% | 8.33% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 56.25% | 37.84% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 180% | 77.78% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/15/20 | 2/17/21 | 2/18/22 | 2/15/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 17.95 | 32.63 | 38.53 | 22.26 | 21.63 | 43.48 | 41.03 | 33.45 | 27.91 | 38.17 | 45 | 40 | 33 |
| EBITDA 1 | -7.65 | 0.069 | -2.436 | -3.478 | 3.962 | - | - | 0.97 | -2.257 | 4.214 | 6 | 5 | 2 |
| EBIT 1 | -11.83 | -4.189 | -6.734 | -7.91 | -9.7 | 0.088 | -0.38 | -2.806 | -6.13 | 0.154 | 2 | 1 | -3 |
| Operating Margin | -65.89% | -12.84% | -17.48% | -35.54% | -44.84% | 0.2% | -0.93% | -8.39% | -21.96% | 0.4% | 4.44% | 2.5% | -9.09% |
| Earnings before Tax (EBT) 1 | -12.42 | -4.825 | -7.513 | -8.72 | -20.66 | -0.958 | -1.714 | -3.899 | -7.517 | -1.534 | - | - | -4 |
| Net income 1 | -11.88 | -5.893 | -8.812 | -9.12 | -20.57 | -0.997 | -2.671 | -4.125 | -7.978 | -2.11 | - | - | -4 |
| Net margin | -66.21% | -18.06% | -22.87% | -40.98% | -95.11% | -2.29% | -6.51% | -12.33% | -28.59% | -5.53% | - | - | -12.12% |
| EPS 2 | -0.1200 | -0.0600 | -0.0900 | -0.0900 | -0.2100 | -0.0100 | -0.0300 | -0.0400 | -0.0800 | -0.0200 | - | -0.0100 | -0.0400 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/18/22 | 5/4/22 | 8/17/22 | 11/10/22 | 2/15/23 | 5/5/23 | 8/17/23 | 11/9/23 | 2/15/24 | 4/30/24 | - | - | - |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 6.11 | 12.9 | 33.3 | 37.7 | 40 | 25 | 17 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -1.369 x | -0.9927 x | -17.69 x | 6.444 x | 2.353 x | 0.7812 x | 0.4595 x |
| Free Cash Flow 1 | - | -13.9 | -52.3 | -22.5 | -8.08 | -8 | 18 | 14 |
| ROE (net income / shareholders' equity) | - | -35.9% | -38.7% | -55.8% | -30.5% | -17.3% | 22.7% | 32.4% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 0.5900 | 1.020 | 0.6000 | 0.4600 | 0.3800 | 0.4800 | 0.6600 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 11.2 | 7.47 | 7.93 | 1.77 | 2 | 1 | 5 |
| Capex / Sales | - | 11.65% | 6.79% | 6.89% | 1.21% | 1.29% | 0.7% | 2.98% |
| Announcement Date | 4/15/20 | 2/17/21 | 2/18/22 | 2/15/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.01% | 35.55M | |
| +23.37% | 69.47B | |
| -3.91% | 46.2B | |
| +25.03% | 44.48B | |
| +38.40% | 29.65B | |
| +14.10% | 19.9B | |
| +14.71% | 17.23B | |
| -10.32% | 14.71B | |
| -28.13% | 14.45B | |
| -30.59% | 11.89B |
- Stock Market
- Equities
- ORGC Stock
- Financials OrganoClick AB
